| Literature DB >> 26518004 |
Yan-Fang Zhang1, Zhi-Xun Xie2, Li-Ji Xie3, Xian-Wen Deng4, Zhi-Qin Xie5, Si-Si Luo6, Li Huang7, Jiao-Ling Huang8, Ting-Ting Zeng9.
Abstract
BACKGROUND: Duck viral pathogens primarily include the avian influenza virus (AIV) subtypes H5, H7, and H9; duck hepatitis virus (DHV); duck tembusu virus (DTMUV); egg drop syndrome virus (EDSV); duck enteritis virus (DEV); Newcastle disease virus (NDV); duck circovirus (DuCV); muscovy duck reovirus (MDRV); and muscovy duck parvovirus (MDPV). These pathogens cause great economic losses to China's duck breeding industry. RESULT: A rapid, specific, sensitive and high-throughput GeXP-based multiplex PCR assay consisting of chimeric primer-based PCR amplification with fluorescent labeling and capillary electrophoresis separation was developed and optimized to simultaneously detect these eleven viral pathogens. Single and mixed pathogen cDNA/DNA templates were used to evaluate the specificity of the GeXP-multiplex assay. Corresponding specific DNA products were amplified from each pathogen. Other pathogens, including duck Escherichia coli, duck Salmonella, duck Staphylococcus aureus, Pasteurella multocida, infectious bronchitis virus, and Mycoplasma gallisepticum, did not result in amplification products. The detection limit of GeXP was 10(3)copies when all twelve pre-mixed plasmids containing the target genes of eleven types of duck viruses were present. To further evaluate the reliability of GeXP, 150 clinical field samples were evaluated. Comparison with the results of conventional PCR methods for the field samples, the GeXP-multiplex PCR method was more sensitive and accurate.Entities:
Mesh:
Year: 2015 PMID: 26518004 PMCID: PMC4628294 DOI: 10.1186/s12866-015-0590-6
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Sources of pathogens used and GeXP assay results
| Pathogen/field samples | Number of samples | Source | Results | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIV- | AIV- | AIV- | AIV- | DHV | DEV | DTMUV | NDV | EDSV | MDRV | MDPV | DuCV | |||
| Reference sample | ||||||||||||||
| acDNA of H5N3 AIV Duck/HK 313/78 | 1 | HKU | + | + | − | − | − | − | − | − | − | − | − | − |
| aH7N2 AIV Duck/HK/ 47/76 | 1 | HKU | + | − | + | − | − | − | − | − | − | − | − | − |
| aH9N6 AIV Duck/HK/147/77 | 1 | HKU | + | − | − | + | − | − | − | − | − | − | − | − |
| bDHV (AV2111) | 1 | CIVDC | − | − | − | − | + | − | − | − | − | − | − | − |
| cDEV (AV1221) | 1 | CIVDC | − | − | − | − | − | + | − | − | − | − | − | − |
| dDTMUV (GX201301,GX201302) | 2 | GVRI | − | − | − | − | − | − | + | − | − | − | − | − |
| eNDV (GX1/00,GX6/02) | 2 | GVRI | − | − | − | − | − | − | − | + | − | − | − | − |
| fEDSV (GEV) | 1 | GVRI | − | − | − | − | − | − | − | − | + | − | − | − |
| gMDRV (NM1,NM2) | 2 | GVRI | − | − | − | − | − | − | − | − | − | + | − | − |
| hMDPV (GX-5,GX-6) | 2 | GVRI | − | − | − | − | − | − | − | − | − | − | + | |
| iDuCV (GX1006,GX1008) | 2 | GVRI | − | − | − | − | − | − | − | − | − | − | − | + |
| Other pathogens | ||||||||||||||
| H1N3 AIVDuck/HK/717/79-d1 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H1N1 AIV Human/NJ/8/76 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H2N3 AIV Duck/HK/77/76 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H3N6 AIV Duck/HK/526/79/2B | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H4N5 AIV Duck/HK/668/79 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H6N8 AIV Duck/HK/531/79 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H8N4AIV Turkey/ont/6118/68 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H10N3 AIV Duck/HK/876/80 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H11N3 AIV Duck/HK/661/79 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H12N5 AIV Duck/HK/862/80 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| H6N8 AIV Duck/HK/531/79 | 1 | HKU | + | − | − | − | − | − | − | − | − | − | − | − |
| duck | 1 | GVRI | − | − | − | − | − | − | − | − | − | − | − | − |
| duck | 1 | GVRI | − | − | − | − | − | − | − | − | − | − | − | − |
| duck | 1 | GVRI | − | − | − | − | − | − | − | − | − | − | − | − |
| Pasteurella multocida | 1 | GVRI | − | − | − | − | − | − | − | − | − | − | − | − |
| Infectious bronchitis virus | 1 | GVRI | − | − | − | − | − | − | − | − | − | − | − | − |
| Mycoplasma gallisepticum | 1 | GVRI | − | − | − | − | − | − | − | − | − | − | − | − |
| Sample mixture | ||||||||||||||
| AIV-H5 + AIV−H7 + AIV−H9 | 1 | GVRI | + | + | + | + | − | − | − | − | − | − | − | − |
| AIV−H5 + DEV + DTMUV + NDV + EDSV | 1 | GVRI | + | + | − | − | − | + | + | + | + | − | − | − |
| AIV−H5 + AIV−H7 + AIV−H9 + DHV + DEV + DTMUV + NDV + EDSV+ MDRV+ MDPV+ DuCV | 1 | GVRI | + | + | + | + | + | + | + | + | + | + | + | + |
HVRI Harbin Veterinary Research Institute, China, HKU The University of HongKong, China, GVRI Guangxi Veterinary Research Institute, China, CIVDC China Institute of Veterinary Drug Control, China, PU University of Pennsylvania
aReferences [23]
bGenBank accession no. : EF442073.1
cGenBank accession no. : EU315247
dGenBank accession no. : KJ700462.1
eGenBank accession no. : JX193083.1
fReferences [35]
gReferences [35]
hGenBank accession no. : KM093740.1
iGenBank accession no. : JX241046.1
Primers used in this study
| Virus | Forward primer sequence (5′−3′) | Reverse primer sequence (5′−3′) | Amplicon size (bp) | Target region |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Universal tag sequences are underlined. Bold type indicates degenerate sites
Abbreviations: M A or C, R A or G, W A or T, S G or C, Y C or T, K G or T, V A, G, or C, H A, C, or T, D A, G, or T; B G, C, or T
Fig. 1Specificity analyses of the GeXP-PCR assay. The Y-axis indicates the dye signal in A.U., and the X-axis indicates the actual PCR product size. a–k show the results of the amplification of AIV-H5, AIV-H7, AIV-H9, DHV, DEV, DTMUV, NDV, EDSV, MDRV, MDPV, and DuCV, respectively. Nuclease-free water was used as the negative control (l). The red peaks indicate the DNA size standard
Fig. 2Sensitivity of the GeXP-PCR assay. Serial 10-fold dilutions of plasmids containing the 12 duck virus types were prepared and amplified in the GeXP-PCR assay using equal amounts of template: 106 (a), 105 (b), 104 (c), 103 (d) and 102 (e) copies per reaction in the GeXP-PCR assay. The viral targets from left to right are as follow: AIV-M, DHV, AIV-H7, DEV, DTMUV, NDV, EDSV, MDRV, AIV-H9, MDPV, AIV-H5, and DuCV. Nuclease-free water was used as the negative control (f)
Fig. 3GeXP-multiplex PCR detection of mixed pathogen templates. The GeXP-multiplex assay was carried out with mixed templates and mixed primers for AIV-H5, AIV-H7 and AIV-H9 (a); AIV-H5, DEV, DTUMV, NDV and EDSV (b); or all eleven viruses (c)
Fig. 4GeXP-multiplex PCR interference assay. GeXP-multiplex PCR was carried out with the following templates: AIV-M + AIV-H9 + DuCV (a), DuCV (b), AIV-M (c), and AIV-H9 (d)
Analysis of clinical samples using the GeXP assay and conventional PCR methods
| Clinical samples | No. of GeXP assay results | No. of conventional PCR method results | ||
|---|---|---|---|---|
| Positive | Negative | Positive | Negative | |
| H9 subtypes of AIV | 20 | 130 | 18 | 132 |
| DHV | 5 | 145 | 5 | 145 |
| DEV | 1 | 149 | 1 | 149 |
| DTMUV | 5 | 145 | 5 | 145 |
| NDV | 10 | 140 | 9 | 141 |
| EDSV | 3 | 142 | 3 | 147 |
| MDRV | 1 | 149 | 1 | 149 |
| MDPV | 4 | 146 | 4 | 146 |
| DuCV | 40 | 110 | 35 | 115 |
| Total | 89 | 61 | 81 | 69 |
Comparison of clinical samples using the GeXP assay and conventional PCR methods
| GeXP assay results | Conventional PCR methods results | Total | |
|---|---|---|---|
| + | − | ||
| + | 81 | 8 | 89 |
| − | 0 | 61 | 61 |
| Total | 81 | 69 | 150 |